526 COMMERCE CIRCLE, MESQUITE, NV
Establishes Collaboration to Conduct Clinical Study
Securities Purchase Agreement with Alumni Capital - $289,821 Loan Secured
Changes in Board, Management or Compensation
Announces OTCQB Uplisting and FDA Update
Other Events
News, Material Contracts
Provides Update on FDA PMA Application and Amendment to White Lion Agreement
Announces Equity Financing Agreement and Provides Corporate Update
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Definitive Proxy Statement
PRE 14A
Definitive Information Statement
Definitive Additional Proxy Soliciting Materials
Preliminary Information Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Notice of Proposed Sale of Securities
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload